CKS1B and familial pancreatic carcinoma: Moreover, multivariable regression analysis further supported that CKS1B independently served as a prognostic indicator in pancreatic cancer patients (HR = 1.554, 95% CI = 1.122-2.152, P = 0.008) (Figure 2B).